PATENT CLAIM ANALYSIS

Application Number: 15962691
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "094610"]

Abstract:
Described herein are methods, systems and compositions for the diagnosis, prognosis and treatment of dementia and Alzheimer's disease. Also described are methods, systems and compositions to distinguish between Alzheimer's disease and Parkinson's disease. In various embodiments levels of PACAP and/or SIRT3 are analyzed for the diagnosis, prognosis and treatment of dementia and Alzheimer's disease.

Claim (Index 17):
The method of  claim 16  and further comprising detecting an expression level of SIRT3 protein in the cerebrospinal fluid sample.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.9697
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15103059', '13983114', '15600959', '12727359', '10543486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6549852177118314
- 35 USC 102 Novelty (BERT): 0.6232939670297503
- Combined Prediction Score: 0.6518160926436233
- Mean Citation Score: 338.85062000000005
- Max Citation Score: 676.0083599999998
- Similarity Product: 479.9943681205772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test